Ketamine has become a popular alternative treatment for depression and other mental-health ailments — but doctors and regulators are increasingly concerned about its risks.
As ketamine therapy booms, industry insiders worry about patient safety
Read Next
- Stocks may rise into the summer. These 3 risks could derail the rally.
- The biggest earnings heavy hitter reports this week, and so do Target and other retailers
- Currency Speculators raise Euro & US Dollar bets into positive levels :: InvestMacro
- The year of AI PCs
- Exclusive: XTX Markets sees 19% decline in 2023 UK Revenues to £2.0 billion
- Speculator bets led higher by Corn & Wheat :: InvestMacro
- Speculator bets led by DowJones-Mini & Russell-Mini :: InvestMacro
